John McCoy
Präsident bei CARDIOVASCULAR SYSTEMS, INC.
Vermögen: 2 Mio $ am 30.04.2024
Aktive Positionen von John McCoy
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CARDIOVASCULAR SYSTEMS, INC. | Präsident | - | - |
| Treasurer | - | - | |
| ABBOTT LABORATORIES | Comptroller/Controller/Auditor | 01.09.2023 | - |
| Corporate Officer/Principal | 01.01.2018 | 01.01.2021 | |
| Treasurer | 01.01.2021 | 01.09.2023 |
Karriereverlauf von John McCoy
Ehemalige bekannte Positionen von John McCoy
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| BAXALTA INC | Comptroller/Controller/Auditor | 01.06.2015 | 01.01.2016 |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Comptroller/Controller/Auditor | 2 |
| Treasurer | 2 |
| President | 1 |
Sektoral
| Health Technology | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Baxalta, Inc.
 Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
Cardiovascular Systems, Inc.
 Cardiovascular Systems, Inc. Medical SpecialtiesHealth Technology Cardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. The company was founded in 1989 and is headquartered in St. Paul, MN. | Health Technology |
- Börse
- Insiders
- John McCoy
- Erfahrung
